Related Experiment Video
Updated: Apr 16, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Multifaceted Modulation of SIRT1 in Cancer and Inflammation
Hui Yang1, Yujing Bi2, Lixiang Xue3
1Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai China; Biotherapy Research Center, Institute of Immunobiology, Fudan University.
Abstract:
SIRT1 is a highly conserved NAD+-dependent protein deacetylase that is involved in diverse cellular processes. SIRT1 can deacetylate not only histones, but also a growing number of nonhistone substrates involved in multiple signaling pathways. Accumulating evidence has indicated that SIRT1 is a key regulator of life span extension, DNA damage, metabolism stress, inflammation, and cancer. In inflammation, SIRT1 deacetylates several transcription factors and regulates the immune cell responses. In cancer, recent discoveries revealed opposite effects of SIRT1 as an oncoprotein or a tumor suppressor under different conditions. In the tumor microenvironment, both infiltrated immune cells and cancer cells can be affected by SIRT1. Understanding the proper cancer-related functions of SIRT1 in both systems may provide potential evidence for SIRT1-based therapies. Here, we discuss the current understanding of SIRT1 in regulating immune responses and tumorigenesis.
Insights
Sirtuin 1 (SIRT1) is a key enzyme regulating inflammation and cancer. It influences immune responses and acts as both an oncoprotein and tumor suppressor, offering potential for novel cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Sirtuin 1 (SIRT1) is a NAD+-dependent deacetylase involved in numerous cellular processes.
- SIRT1 targets both histone and non-histone proteins, impacting signaling pathways.
- Evidence links SIRT1 to lifespan, DNA repair, metabolic stress, inflammation, and cancer.
Purpose of the Study:
- To review the role of SIRT1 in immune responses.
- To discuss the dual role of SIRT1 in tumorigenesis.
- To explore SIRT1's impact on the tumor microenvironment for therapeutic insights.
Main Methods:
- Literature review of studies on SIRT1 function.
- Analysis of SIRT1's deacetylase activity on various substrates.
- Examination of SIRT1's involvement in inflammatory and cancer pathways.
Main Results:
- SIRT1 modulates immune cell responses by deacetylating transcription factors.
- SIRT1 exhibits context-dependent roles in cancer, acting as an oncoprotein or tumor suppressor.
- SIRT1 affects both cancer cells and immune cells within the tumor microenvironment.
Conclusions:
- SIRT1 is a critical regulator of inflammation and immunity.
- Understanding SIRT1's complex role in cancer is crucial for developing targeted therapies.
- SIRT1-based strategies may offer new avenues for cancer treatment by modulating the tumor microenvironment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
